These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 27184686

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Survival, graft function, and incidence of allograft vasculopathy in heart transplant patients receiving adverse risk profile donor hearts.
    Berg K, Clemmensen TS, Tram EM, Koefoed-Nielsen P, Ilkjaer LB, Poulsen SH, Eiskjaer H.
    Clin Transplant; 2018 Aug; 32(8):e13343. PubMed ID: 29974979
    [Abstract] [Full Text] [Related]

  • 6. Sequential Versus Combined Heart-Liver Transplantation in the USA.
    Yamaguchi Y, Burrier C, Roth C, Tumin D, Beal EW, Washburn K, Hayes D, Tobias JD.
    Dig Dis Sci; 2020 Aug; 65(8):2427-2432. PubMed ID: 31776860
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Post-transplant donor specific antibody is associated with poor kidney transplant outcomes only when combined with both T-cell-mediated rejection and non-adherence.
    Cherukuri A, Mehta R, Sharma A, Sood P, Zeevi A, Tevar AD, Rothstein DM, Hariharan S.
    Kidney Int; 2019 Jul; 96(1):202-213. PubMed ID: 31029504
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: Analysis of UNOS Database.
    Simpson N, Cho YW, Cicciarelli JC, Selby RR, Fong TL.
    Transplantation; 2006 Nov 27; 82(10):1298-303. PubMed ID: 17130778
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.
    Loupy A, Vernerey D, Tinel C, Aubert O, Duong van Huyen JP, Rabant M, Verine J, Nochy D, Empana JP, Martinez F, Glotz D, Jouven X, Legendre C, Lefaucheur C.
    J Am Soc Nephrol; 2015 Jul 27; 26(7):1721-31. PubMed ID: 25556173
    [Abstract] [Full Text] [Related]

  • 15. Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation.
    Clerkin KJ, Farr MA, Restaino SW, Zorn E, Latif F, Vasilescu ER, Marboe CC, Colombo PC, Mancini DM.
    J Heart Lung Transplant; 2017 May 27; 36(5):540-545. PubMed ID: 27916323
    [Abstract] [Full Text] [Related]

  • 16. Response to treatment and long-term outcomes in kidney transplant recipients with acute T cell-mediated rejection.
    Bouatou Y, Viglietti D, Pievani D, Louis K, Duong Van Huyen JP, Rabant M, Aubert O, Taupin JL, Glotz D, Legendre C, Loupy A, Lefaucheur C.
    Am J Transplant; 2019 Jul 27; 19(7):1972-1988. PubMed ID: 30748089
    [Abstract] [Full Text] [Related]

  • 17. Belatacept rescue for delayed kidney allograft function in a patient with previous combined heart-liver transplant.
    Kumar D, Yakubu I, Cooke RH, Halloran PF, Gupta G.
    Am J Transplant; 2018 Oct 27; 18(10):2613-2614. PubMed ID: 29981184
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of cardiac allograft vasculopathy incidence between simultaneous multiorgan and isolated heart transplant recipients in the United States.
    Shahandeh N, Kim JS, Klomhaus AM, Tehrani DM, Hsu JJ, Nsair A, Khush KK, Fearon WF, Parikh RV.
    J Heart Lung Transplant; 2024 Oct 27; 43(10):1737-1746. PubMed ID: 38950666
    [Abstract] [Full Text] [Related]

  • 19. Late graft failure in heart transplant recipients: incidence, risk factors and clinical outcomes.
    López-Sainz Á, Barge-Caballero E, Barge-Caballero G, Couto-Mallón D, Paniagua-Martin MJ, Seoane-Quiroga L, Iglesias-Gil C, Herrera-Noreña JM, Cuenca-Castillo JJ, Vázquez-Rodríguez JM, Crespo-Leiro MG.
    Eur J Heart Fail; 2018 Feb 27; 20(2):385-394. PubMed ID: 28580728
    [Abstract] [Full Text] [Related]

  • 20. Granulocyte colony-stimulating factor therapy is associated with a reduced incidence of acute rejection episodes or allograft vasculopathy in heart transplant recipients.
    Vrtovec B, Haddad F, Pham M, Deuse T, Fearon WF, Schrepfer S, Leon S, Vu T, Valantine H, Hunt SA.
    Transplant Proc; 2013 Feb 27; 45(6):2406-9. PubMed ID: 23953556
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.